# 52-104 Week Off-therapy Second Extension to Study CSPP100A2365

> **NCT01420068** · — · COMPLETED · sponsor: **Noden Pharma** · enrollment: 106 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** SPP100

## Key facts

- **NCT ID:** NCT01420068
- **Lead sponsor:** Noden Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-19
- **Primary completion:** 2017-08-03
- **Final completion:** 2017-08-03
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420068, "52-104 Week Off-therapy Second Extension to Study CSPP100A2365". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01420068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*